Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?3.3mm NC, SLA? 8mm, TiZr, Loxim: medical device reports filed with FDA

11,091 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

11,091
device reports naming the brand
0% of all MAUDE reports · about 1,604 a year
2,405
reports, 12 months to August 2026
2,357 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 11,091 reports that name the brand "BLT ?3.3mm NC, SLA? 8mm, TiZr, Loxim" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

2,405 reports arrived in the 12 months to August 2026, close to the 2,357 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (71.2%), loss of osseointegration (25.8%) and fracture (0.8%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0289577Sep 2021: 56Oct 2021: 62Nov 2021: 100Dec 2021: 622022Jan 2022: 138Feb 2022: 86Mar 2022: 94Apr 2022: 118May 2022: 106Jun 2022: 99Jul 2022: 91Aug 2022: 143Sep 2022: 130Oct 2022: 122Nov 2022: 103Dec 2022: 1372023Jan 2023: 124Feb 2023: 97Mar 2023: 125Apr 2023: 152May 2023: 106Jun 2023: 119Jul 2023: 118Aug 2023: 158Sep 2023: 107Oct 2023: 144Nov 2023: 137Dec 2023: 1522024Jan 2024: 125Feb 2024: 162Mar 2024: 138Apr 2024: 192May 2024: 178Jun 2024: 132Jul 2024: 175Aug 2024: 180Sep 2024: 172Oct 2024: 252Nov 2024: 263Dec 2024: 1982025Jan 2025: 175Feb 2025: 132Mar 2025: 170Apr 2025: 81May 2025: 0Jun 2025: 577Jul 2025: 178Aug 2025: 159Sep 2025: 177Oct 2025: 246Nov 2025: 198Dec 2025: 2012026Jan 2026: 172Feb 2026: 187Mar 2026: 189Apr 2026: 233May 2026: 236Jun 2026: 188Jul 2026: 207Aug 2026: 171

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01,1472,2942019: 47620192020: 70920202021: 95620212022: 1,36720222023: 1,53920232024: 2,16720242025: 2,29420252026: 1,5832026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%11,091
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report90.4%10,027
Voluntary report0%0
User facility report0%0
Distributor report9.6%1,064
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate7,89571.2%62.8%
Loss of osseointegration2,85625.8%22.4%
Fracturea broken bone860.8%1.6%
Difficult to insertthe device was hard to insert470.4%0.4%
Separation failure150.1%0.1%
Unintended movement80.1%0%
Unstable50%0%
Difficult to removethe device was hard to remove20%0%
Defective component10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis3,88635%
Painpain, site not specified2,33421%
Tissue damage7006.3%
Inflammationinflammation6555.9%
Hemorrhage/blood loss/bleeding6255.6%
Swelling/ edema5414.9%
Fistula3633.3%
Hyperresponsive to stimuli1851.7%
Abscessa collection of pus1731.6%
Hypersensitivity/allergic reaction1151%
Failure of implant480.4%
Swellingswelling480.4%
Numbnessnumbness430.4%
Sinus perforation300.3%
Inadequate osseointegration260.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?3.3mm NC, SLA? 8mm, TiZr, LoximProduct code DZEAll MAUDE reports
Reports11,0913,924,24126,136,888
Share of that pool—0.3%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer90.4%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?3.3mm NC, SLA? 8mm, TiZr, Loxim reports

How many FDA reports name BLT ?3.3mm NC, SLA? 8mm, TiZr, Loxim?

11,091 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 2,405 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (71.2%), loss of osseointegration (25.8%), fracture (0.8%), difficult to insert (0.4%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (90.4%) and distributor reports (9.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?3.3mm NC, SLA? 8mm, TiZr, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.